Kodiak Sciences Inc Sustainability Reports
Kodiak Sciences Inc. is a clinical-stage biotechnology company that focuses on the research, development, and commercialization of therapeutics to treat retinal vascular diseases. The company utilizes its proprietary Antibody Biopolymer Conjugate platform to design next-generation medicines for high-prevalence ophthalmic conditions.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 254900IXI5NI8C9OQE24
FIGI: BBG00BVR0D11
6 reports from 2021 to 2025
